Abridge: Building the AI Platform for Clinical Conversations
Abridge is an AI-native healthcare platform that turns patient-clinician conversations into clinically useful documentation, evidence-linked insights and actionable outputs across the healthcare workflow.
Visit abridge.com ↗Basic Information
| Field | Detail |
|---|---|
Company Name | Abridge |
Category | Healthcare AI |
Subcategory | Clinical Intelligence, Ambient AI & Healthcare Workflow Automation |
Founded | 2018 |
Headquarters | San Francisco, California, with roots in Pittsburgh |
Latest Stage | Series E Extension |
Total Funding | Approximately $830 million |
Latest Funding | $316 million Series E extension · April 2026 |
Latest Valuation | $5.3 billion · April 2026 |
Founder | Dr. Shiv Rao |
CEO | Dr. Shiv Rao |
Core Product | AI-native clinician intelligence platform |
Website | abridge.com ↗ |
What Abridge Does
Abridge uses purpose-built AI to understand patient-clinician conversations and convert them into clinical documentation and other useful outputs inside healthcare workflows. Its platform is designed for outpatient, emergency and inpatient settings and integrates with electronic health records.
Key Strengths
- AI built specifically for clinical conversations
- Evidence-linked and auditable AI-generated outputs
- Deep EHR workflow integration
- Multilingual support across specialties and care settings
- Expansion from documentation into broader clinical intelligence
Why It Matters
Abridge is moving beyond the AI scribe category by using the clinical conversation as a foundation for documentation, coding, decision support, prior authorization and other healthcare workflows.
Abridge at Scale
300+
Health Systems
Abridge said in September 2026 that its platform was trusted by more than 300 of the largest health systems in the U.S.
100M+
Patient Conversations
The company expects its platform to support more than 100 million patient-clinician conversations in 2026.
250M+
Patients Represented
Partner health systems collectively represent more than 250 million patients, according to Abridge.
Platform & Clinical Intelligence
Ambient Clinical Documentation
Abridge captures the clinical conversation and generates structured notes that can be reviewed and incorporated into the electronic health record.
Linked Evidence
AI-generated summaries can be mapped back to source information, helping clinicians verify outputs and understand the evidence behind generated content.
Contextual Reasoning
Abridge’s Contextual Reasoning Engine incorporates information from the patient chart, conversation, prior encounters, health-system guidance and clinician preferences.
Actionable Outputs
The platform is expanding toward outputs such as clinical orders, coding support, prior authorization and other workflow actions that can be reviewed by clinicians.
Enterprise EHR Integration
Abridge is designed to operate within existing EHR workflows and has expanded across large academic, community and specialty health systems.
AI Foundation Models
In 2026, Abridge announced collaboration with NVIDIA on a foundation model purpose-built for clinical conversations rather than adapting a general-purpose model to healthcare.
Enterprise Momentum
Large Health Systems
Abridge has announced deployments and enterprise implementations with organizations including Mayo Clinic, Johns Hopkins Medicine, Duke Health, Yale New Haven Health and Northwestern Medicine.
Clinical Decision Support
Since launching broader context-aware clinical intelligence, more than 300 partner health systems have adopted the capability, according to Abridge.
Federal Healthcare
In September 2026, Abridge was selected to provide ambient AI through a U.S. Department of Veterans Affairs enterprise contract covering nationwide veteran care.
Funding Journey
October 2023
Series B
$30M
Led by Spark Capital
February 2024
Series C
$150M
Led by Lightspeed & Redpoint
February 2025
Series D
$250M
$2.75B valuation
2025–2026
Series E + Extension
$616M
$300M Series E plus $316M extension; $5.3B valuation